Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Greenfield

Showing results (111-120 of 280) with videos related to

Pageof 28
Sort By:
The Medical Journal of Australia|September 27, 2006
Diabetes guidelines: easier to preach than to practise?Wendy Bryant, Jerry R Greenfield, Donald J Chisholm, et al.
Obesity Research|April 12, 2002
Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomographyJerry R Greenfield, Katherine Samaras, Donald J Chisholm, et al.
Journal of the American Geriatrics Society|June 4, 2009
Weight maintenance in hospitalized geriatric patients treated with beta-blockersPaul Lee, Jerry R Greenfield, Richard O Day, et al.
Anaesthesia and Intensive Care|April 8, 2010
New insulin analogues and perioperative care of patients with type 1 diabetesJ Killen, K Tonks, J R Greenfield, et al.
Nutrients|March 27, 2015
L-glutamine and whole protein restore first-phase insulin response and increase glucagon-like peptide-1 in type 2 diabetes patientsDorit Samocha-Bonet, Don J Chisholm, Jens J Holst, et al.
Drug Safety|October 23, 2020
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney DiseaseTamara Y Milder, Sophie L Stocker, Richard O Day, et al.
Drug Safety|October 17, 2023
Sodium-Glucose Cotransporter 2 Inhibitor-Associated "Ketoacidosis" Versus "Diabetic Ketoacidosis": The Importance of Accurate TerminologyTamara Y Milder, David A Milder, Jerry R Greenfield, et al.
International Journal of Obesity (2005)|May 30, 2012
Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in menP Lee, R O Day, J R Greenfield, et al.
Radiology|September 1, 1975
Compartmental evaluation of osteoarthritis of the knee. A comparative study of available diagnostic modalitiesR H Thomas, D Resnick, N P Alazraki, et al.
Internal Medicine Journal|May 21, 2020
Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetesTamara Y Milder, Richard O Day, Sophie L Stocker, et al.
Pageof 28

Showing results (111-120 of 280) with videos related to

Sort By:
Pageof 28
The Medical Journal of Australia|September 27, 2006
Diabetes guidelines: easier to preach than to practise?Wendy Bryant, Jerry R Greenfield, Donald J Chisholm, et al.
Obesity Research|April 12, 2002
Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomographyJerry R Greenfield, Katherine Samaras, Donald J Chisholm, et al.
Journal of the American Geriatrics Society|June 4, 2009
Weight maintenance in hospitalized geriatric patients treated with beta-blockersPaul Lee, Jerry R Greenfield, Richard O Day, et al.
Anaesthesia and Intensive Care|April 8, 2010
New insulin analogues and perioperative care of patients with type 1 diabetesJ Killen, K Tonks, J R Greenfield, et al.
Nutrients|March 27, 2015
L-glutamine and whole protein restore first-phase insulin response and increase glucagon-like peptide-1 in type 2 diabetes patientsDorit Samocha-Bonet, Don J Chisholm, Jens J Holst, et al.
Drug Safety|October 23, 2020
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney DiseaseTamara Y Milder, Sophie L Stocker, Richard O Day, et al.
Drug Safety|October 17, 2023
Sodium-Glucose Cotransporter 2 Inhibitor-Associated "Ketoacidosis" Versus "Diabetic Ketoacidosis": The Importance of Accurate TerminologyTamara Y Milder, David A Milder, Jerry R Greenfield, et al.
International Journal of Obesity (2005)|May 30, 2012
Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in menP Lee, R O Day, J R Greenfield, et al.
Radiology|September 1, 1975
Compartmental evaluation of osteoarthritis of the knee. A comparative study of available diagnostic modalitiesR H Thomas, D Resnick, N P Alazraki, et al.
Internal Medicine Journal|May 21, 2020
Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetesTamara Y Milder, Richard O Day, Sophie L Stocker, et al.
Pageof 28